General Information of Drug (ID: DMS8QF9)

Drug Name
Arimoclomol Drug Info
Synonyms BRX-345
Indication
Disease Entry ICD 11 Status REF
Cerebrovascular ischaemia 8B1Z Phase 2/3 [1]
Inclusion body myositis 4A41.2 Phase 2/3 [2]
Cross-matching ID
PubChem CID
9568077
CAS Number
CAS 289893-25-0
TTD Drug ID
DMS8QF9

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug(s) Targeting Heat shock protein (HSP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Heat shock protein vaccine DM9OZU5 Meningococcal infection 1C1C Phase 2 [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Heat shock protein (HSP) TTG91S4 NOUNIPROTAC Modulator [3]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8271).
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Arimoclomol, a coinducer of heat shock proteins for the potential treatment of amyotrophic lateral sclerosis. IDrugs. 2010 Jul;13(7):482-96.
4 Heat shock proteins (HSPs) based anti-cancer vaccines. Curr Mol Med. 2012 Nov 1;12(9):1183-97.